Access to anti-retroviral drugs, female in Chad
Chad: Access to anti-retroviral drugs, female was 72.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Chad, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Chad stood at 72.0%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 9.1% on the previous year and up 100.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Chad peaked at 72.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Chad 76th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Chad, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 2.0% | — |
| 2006 | 6.0% | +200.0% |
| 2007 | 10.0% | +66.7% |
| 2008 | 14.0% | +40.0% |
| 2009 | 18.0% | +28.6% |
| 2010 | 22.0% | +22.2% |
| 2011 | 26.0% | +18.2% |
| 2012 | 29.0% | +11.5% |
| 2013 | 33.0% | +13.8% |
| 2014 | 36.0% | +9.1% |
| 2015 | 40.0% | +11.1% |
| 2016 | 44.0% | +10.0% |
| 2017 | 47.0% | +6.8% |
| 2018 | 47.0% | +0.0% |
| 2019 | 50.0% | +6.4% |
| 2020 | 55.0% | +10.0% |
| 2021 | 59.0% | +7.3% |
| 2022 | 62.0% | +5.1% |
| 2023 | 66.0% | +6.5% |
| 2024 | 72.0% | +9.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.0% | 0.0% | 18.0% | 10 |
| 2010s | 37.4% | 22.0% | 50.0% | 10 |
| 2020s | 62.8% | 55.0% | 72.0% | 5 |
Countries ranked near Chad
More gender data for Chad
- Child population (UN estimates and projections) 10,979 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 2.4 % change on previous year (2030)
- Population 13,228 (2030)
- Working-age population (UN estimates and projections) 13,228 (2030)
- Age population, age 00, female, interpolated 418,285 (2025)
- Age population, age 00, male, interpolated 432,344 (2025)
- Age population, age 01, female, interpolated 393,366 (2025)
- Age population, age 01, male, interpolated 404,768 (2025)
- Age population, age 02, female, interpolated 373,072 (2025)
- Age population, age 02, male, interpolated 383,496 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Chad?
- Access to anti-retroviral drugs, female in Chad was 72.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Chad?
- The highest recorded value was 72.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Chad?
- The lowest recorded value was 0.0% in 2000.
- How does Chad rank for access to anti-retroviral drugs, female?
- Chad ranks 76th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Chad?
- Over the last ten years it is up 100.0%. The long-run trend across the full record is volatile.
- Where does this Chad data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.